Literature DB >> 31085106

An Overview of Cancer Pain: Epidemiology and Pathophysiology.

Marguerite M Russo1, Thiruppavai Sundaramurthi2.   

Abstract

OBJECTIVE: To present an overview of the epidemiology and pathophysiology of cancer pain related to disease and treatment. DATA SOURCES: Published manuscripts, Web sites, and textbook chapters.
CONCLUSION: Current knowledge of cancer pain epidemiology and pathophysiology widens and focuses the opportunities to prevent, limit, and treat cancer pain. IMPLICATIONS FOR NURSING PRACTICE: Nurses' knowledge of transduction, transmission, perception, and modulation in cancer pain pathophysiology outlines pathways for multimodal approaches to treat complex and diverse pain experiences. Use of standard vocabulary of pain terms and definitions facilitates pain assessment and management across different disciplines.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Cancer pain; Cancer pain epidemiology; Cancer pain pathophysiology; Cancer pain syndromes

Mesh:

Year:  2019        PMID: 31085106     DOI: 10.1016/j.soncn.2019.04.002

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  10 in total

1.  A Comparative Study of Seminars Combined with Case-Based Learning versus Lecture-Based Learning for Cancer Pain Teaching in Medical Oncology Internship.

Authors:  Yan Yang; Jing-Hao Yao; Ling-Jie Xu; Zheng-Guang Zhou; Ming-Xi Wang; Zi-Shu Wang; Fu-You Zhao
Journal:  J Pain Res       Date:  2021-08-28       Impact factor: 3.133

2.  A Survey of Knowledge and Barriers of Healthcare Professionals toward Opioid Analgesics in Cancer Pain Management.

Authors:  Nehad M Ayoub; Malak Jibreel; Khawla Nuseir; Ghaith M Al-Taani
Journal:  Int J Clin Pract       Date:  2022-04-12       Impact factor: 3.149

3.  Morphine inhibits the promotion of inflammatory microenvironment on chronic tibial cancer pain through the PI3K-Akt-NF-κB pathway.

Authors:  Diyang Ling; Yan Zhao; Zhenwu Zhang; Jiaya Li; Chunhui Zhu; Zheyin Wang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

4.  F7 and topotecan co-loaded thermosensitive liposome as a nano-drug delivery system for tumor hyperthermia.

Authors:  Chunyang Du; Shuangshuang Li; Yuan Li; Hervé Galons; Na Guo; Yuou Teng; Yongmin Zhang; Mingyuan Li; Peng Yu
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

5.  An Investigation of the Molecular Mechanisms Underlying the Analgesic Effect of Jakyak-Gamcho Decoction: A Network Pharmacology Study.

Authors:  Ho-Sung Lee; In-Hee Lee; Kyungrae Kang; Sang-In Park; Tae-Wook Kwon; Dae-Yeon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-01       Impact factor: 2.629

6.  The Challenge of Cancer Pain Assessment.

Authors:  Radhika Rani Gulati
Journal:  Ulster Med J       Date:  2021-02-26

7.  Barriers to cancer pain management from the perspective of patients: A qualitative study.

Authors:  Samira Orujlu; Hadi Hassankhani; Azad Rahmani; Zohreh Sanaat; Abbas Dadashzadeh; Atefeh Allahbakhshian
Journal:  Nurs Open       Date:  2021-10-17

Review 8.  A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer.

Authors:  Hilla Mills; Ronald Acquah; Nova Tang; Luke Cheung; Susanne Klenk; Ronald Glassen; Magali Pirson; Alain Albert; Duong Trinh Hoang; Thang Nguyen Van
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-09       Impact factor: 2.650

Review 9.  Practical Considerations for the Use of Cannabis in Cancer Pain Management-What a Medical Oncologist Should Know.

Authors:  Alecsandra Gorzo; Andrei Havași; Ștefan Spînu; Adela Oprea; Claudia Burz; Daniel Sur
Journal:  J Clin Med       Date:  2022-08-27       Impact factor: 4.964

10.  β-Elemene Improves Morphine Tolerance in Bone Cancer Pain via N-Methyl-D-Aspartate Receptor 2B Subunit-Mediated μ-Opioid Receptor.

Authors:  Qinfei Zhou; Liyan Gong; Guanai Bao; Qunfang Ding; Jingjing Ji
Journal:  Comput Math Methods Med       Date:  2022-09-17       Impact factor: 2.809

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.